The latest closing stock price for Cidara Therapeutics as of June 20, 2025 is 21.02.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-934 today, roughly -1 times their original investment - a -23.84% compound annual growth rate over 10 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 28.42, which is 35.2% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.14, which is 51.8% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 17.70.
An investor who bought $1,000 worth of Cidara Therapeutics stock at the IPO in 2015 would have $-934 today, roughly -1 times their original investment - a -23.84% compound annual growth rate over 10 years.
The all-time high Cidara Therapeutics stock closing price was 345.20 on December 30, 2015.
The Cidara Therapeutics 52-week high stock price is 28.42, which is 35.2% above the current share price.
The Cidara Therapeutics 52-week low stock price is 10.14, which is 51.8% below the current share price.
The average Cidara Therapeutics stock price for the last 52 weeks is 17.70.